MICHELLE BURNHAM: Open Payments
NPI 1275781254 · VAN BUREN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 75 payments from 16 companies in 2025. Trend: 2023 $120 · 2024 $1,077 · 2025 $1,396
Food & beverage: $1,396
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $268 |
| Janssen Biotech, Inc. | 15 | $209 |
| LEO Pharma Inc. | 8 | $185 |
| Lilly USA, LLC | 9 | $169 |
| UCB, Inc. | 4 | $142 |
| GENZYME CORPORATION | 4 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $65 |
| BioWound Solutions, Inc. | 2 | $54 |
| Botanix SB Inc | 3 | $52 |
| Incyte Corporation | 2 | $44 |
Products named: TREMFYA, TALTZ, ADBRY, Bimzelx, SKYRIZI, RINVOQ, DUPIXENT, bio-ConneKt.
Industry payments across MO — which companies pay providers there.
